Product Information

PITAVASTATIN 2 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9122 per EA under NDC 65862081390. Its NADAC has been published 149 times since Jan 17, 2024.

FDA first approved this application on Dec 20, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PITAVASTATIN 2 MG TABLET

Pitavastatin
$0.9122per EA

Strength

2 mg/1

NDC

65862081390

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PITAVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206015

FDA Approved

12/20/2016

TE Code

AB

On Market Since

11/2/2023

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for PITAVASTATIN 2 MG TABLET has been published 149 times since Jan 17, 2024, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9122 per EA
All-time high$2.4472 (Apr 10, 2024)
All-time low$0.9122 (Nov 18, 2026)
52-week high$1.3654
52-week low$0.9122
Median price$1.4525
Average price$1.4957
Largest weekly change-32.5% (Nov 20, 2024)
Weeks tracked149
Tracking sinceJan 17, 2024

Price History

1W

-5.9%

1M

-4.4%

3M

-7.5%

6M

-25.0%

1Y

-33.2%

3Y

N/A

5Y

N/A

All

-55.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PITAVASTATIN 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 2 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.9122 per EA (NDC 65862081390), effective Nov 18, 2026.

How has the price of PITAVASTATIN 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for PITAVASTATIN 2 MG TABLET has declined 55.5%. It has been tracked across 149 weekly CMS publications since Jan 17, 2024.

What are the highest and lowest recorded NADAC prices for PITAVASTATIN 2 MG TABLET?

Since Jan 17, 2024, the NADAC for PITAVASTATIN 2 MG TABLET has ranged from a low of $0.9122 (Nov 18, 2026) to a high of $2.4472 (Apr 10, 2024), with a median of $1.4525 per EA.

Are there cheaper alternatives to PITAVASTATIN 2 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PITAVASTATIN 2 MG TABLET?

PITAVASTATIN 2 MG TABLET (NDC 65862081390) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.